Therapeutic efficacy and safety of red blood cells treated with a chemical process (S-303) for pathogen inactivation: A Phase III clinical trial in cardiac surgery patients
Richard J. Benjamin, Jeffrey McCullough, Paul D. Mintz, Edward Snyder, William D. Spotnitz, Robert J. Rizzo, David Wages, Jin Sying Lin, Lindsey Wood, Laurence Corash, Maureen G. Conlan
Dive into the research topics of 'Therapeutic efficacy and safety of red blood cells treated with a chemical process (S-303) for pathogen inactivation: A Phase III clinical trial in cardiac surgery patients'. Together they form a unique fingerprint.